Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

NCT07637851 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Ubamatamab
DRUG: Chemotherapy
DRUG: Bevacizumab
DRUG: GCSF

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]